These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparing Bayesian early stopping boundaries for phase II clinical trials. Jiang L; Yan F; Thall PF; Huang X Pharm Stat; 2020 Nov; 19(6):928-939. PubMed ID: 32720462 [TBL] [Abstract][Full Text] [Related]
7. Creation and implementation of a historical controls database from randomized clinical trials. Desai JR; Bowen EA; Danielson MM; Allam RR; Cantor MN J Am Med Inform Assoc; 2013 Jun; 20(e1):e162-8. PubMed ID: 23449762 [TBL] [Abstract][Full Text] [Related]
8. Gemcitabine: monochemotherapy of breast cancer. Ferrazzi E; Stievano L Ann Oncol; 2006 May; 17 Suppl 5():v169-72. PubMed ID: 16807449 [TBL] [Abstract][Full Text] [Related]
9. Gemcitabine in the management of metastatic breast cancer: a systematic review. Dent S; Messersmith H; Trudeau M Breast Cancer Res Treat; 2008 Apr; 108(3):319-31. PubMed ID: 17530427 [TBL] [Abstract][Full Text] [Related]
10. A Bayesian re-assessment of two Phase II trials of gemcitabine in metastatic nasopharyngeal cancer. Tan SB; Machin D; Tai BC; Foo KF; Tan EH Br J Cancer; 2002 Mar; 86(6):843-50. PubMed ID: 11953813 [TBL] [Abstract][Full Text] [Related]
11. Bayesian two-stage designs for phase II clinical trials. Tan SB; Machin D Stat Med; 2002 Jul; 21(14):1991-2012. PubMed ID: 12111883 [TBL] [Abstract][Full Text] [Related]
12. Gemcitabine for patients with relapsed nasopharyngeal carcinoma. Mileshkin L; Rischin D Intern Med J; 2002; 32(5-6):275-6. PubMed ID: 12036230 [No Abstract] [Full Text] [Related]
13. Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials. Fang W; Yang Y; Ma Y; Hong S; Lin L; He X; Xiong J; Li P; Zhao H; Huang Y; Zhang Y; Chen L; Zhou N; Zhao Y; Hou X; Yang Q; Zhang L Lancet Oncol; 2018 Oct; 19(10):1338-1350. PubMed ID: 30213452 [TBL] [Abstract][Full Text] [Related]
14. Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy. Zhang L; Zhang Y; Huang PY; Xu F; Peng PJ; Guan ZZ Cancer Chemother Pharmacol; 2008 Jan; 61(1):33-8. PubMed ID: 17909810 [TBL] [Abstract][Full Text] [Related]
15. Gemcitabine monotherapy in patients with heavily treated nasopharyngeal cancer: a case series. Enokida T; Uozumi S; Fujisawa T; Ueda Y; Okano S; Tahara M Int J Clin Oncol; 2017 Dec; 22(6):1009-1014. PubMed ID: 28616753 [TBL] [Abstract][Full Text] [Related]